Gelteq Limited (GELS)
NASDAQ: GELS · Real-Time Price · USD
2.660
-0.220 (-7.64%)
At close: Apr 23, 2025, 4:00 PM
2.440
-0.220 (-8.27%)
Pre-market: Apr 24, 2025, 7:35 AM EDT

Gelteq Revenue

In the fiscal year ending June 30, 2024, Gelteq had annual revenue of 143.31K AUD, down -58.21%. Gelteq had revenue of 31.90K in the quarter ending June 30, 2024.

Revenue (ttm)
143.31K AUD
Revenue Growth
-61.48%
P/S Ratio
225.84
Revenue / Employee
17,914 AUD
Employees
8
Market Cap
25.11M USD

Revenue Chart

* This company reports financials in AUD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 2024143.31K-199.59K-58.21%
Jun 30, 2023342.90K-29.17K-7.84%
Jun 30, 2022372.07K212.20K132.73%
Jun 30, 2021159.87K--
Jun 30, 2020---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 64.17B
AbbVie 56.33B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.88B
Revenue Rankings